Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical and Translational Allergy is Scopus-indexed (Q1, CiteScore 6.7), WoS SCIE, DOAJ. Published by John Wiley & Sons Inc..
Checked against the index lists dated .
ISSN 2045-7022Verify ISSN ↗
Publisher: John Wiley & Sons Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 29 / 165 | 82nd | Q1 |
| Immunology and Allergy | 72 / 234 | 69th | Q2 |
| Immunology | 81 / 243 | 66th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2011–present, best quartile Q1, CiteScore 6.7.
Clinical and Translational Allergy is Q1 in Pulmonary and Respiratory Medicine (rank 29 of 165), Q2 in Immunology and Allergy (rank 72 of 234) and Q2 in Immunology (rank 81 of 243), by CiteScore 2025.
Clinical and Translational Allergy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.7, which places it in quartile Q1 at the 82nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.396, quartile Q1, with an H-index of 60.
The publisher lists an article processing charge of about US$3,690 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Clinical and Translational Allergy is published by John Wiley & Sons Inc. Its ISSN is 2045-7022.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Clinical and Translational Allergy has an h-index of 69 and a 2-year mean of 3.09 citations per paper (OpenAlex). Its Scopus CiteScore is 6.7, quartile Q1. On 2-year citations it ranks #27 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
Clinical and Translational Allergy published 136 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from China (16.1%), Germany (10.7%) and Italy (8.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (1.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.